Skip to content
Austin Top 50
Author:
Privo Technologies
/C O R R E C T I O N — Privo Technologies/
October 7, 2026
Clinical Update from the Ongoing Phase 2 Trial of PRV111, the First Non-Surgical Therapy in Development for Early-Stage Oral Cancer
October 5, 2026